发现抗体/DMAB-二氢阿那滨/10 mg/D-110-10 mg

价格
¥820.00
货号:D-110-10mg
浏览量:127
品牌:Discovery
服务
全国联保
正品保证
正规发票
签订合同
商品描述
Cat #: T-120
Alternative Name Mydriacyl®
  • Lyophilized Powder
  • Bioassay Tested
  • Source Synthetic
    MW: 284.3
    Purity: >96%
    Effective concentration 10 nM - 100 µM.
      • Tropicamide
    Chemical name N-Ethyl-3-hydroxy-2-phenyl-N-(pyridinylmethyl)propanamide.
    Molecular formula C17H20N2O2.
    CAS No.: 1508-75-4.
    Activity Tropicamide is a muscarinic receptor (mAChR) antagonist, which shows a 3 fold selectivity for M4 over other muscarinic receptors1-2. Tropicamide inhibits porcine intravesical ureter contraction with pIC50 of ~7.53.
      • Liao, C.F. et al. (1989) J. Biol. Chem. 264, 7328.
      • Lazareno, S. et al. (1990) Br. J. Pharmacol. 109, 1120.
      • Hernandez, M. et al. (1993) Br. J. Pharmacol. 110, 1413.
    Shipping and storage Shipped at room temperature. Product as supplied can be stored intact at room temperature for several weeks. For longer periods, it should be stored at -20°C.
    Solubility DMSO. Centrifuge all product preparations before use (10000 x g 5 min).
    Storage of solutions Up to four weeks at 4°C or three months at -20°C.
      • Tropicamide
        Alomone Labs Tropicamide inhibits carbachol’s effect on M1 mAChR expressed in C6 cells.
        Cells were loaded with Fluo-3 AM and changes in intracellular Ca2+ were detected via changes in Fluo-3 emission. A. Normalized fluorescence before and after application (at 20 seconds, see arrow) of 10 μM Carbachol following a 20 min incubation with 0-100 μM Tropicamide (#T-120) (as indicated). B. Inhibition (as percent of control) of 10 µM Carbachol evoked Ca2+ rise, plotted against Tropicamide concentrations.
    References - Scientific background
    • 1. Bonner, T.I. et al. (1989) Trends. Neurosci. 12, 148.
    • 2. Felder, C.C. et al. (1995) FASEB. J. 9, 619.
    • 3. Bonner, T.I. et al. (1987) Science 237, 527.
    • 4. Peralta, E.G. et al. (1987) EMBO J.  6, 3923.
    • 5. Bonner, T.I. et al. (1988) Neuron 1, 403.
    • 6. Liao, C.F. et al. (1989) J. Biol. Chem. 264, 7328.
    • 7. Liao, C.F. et al. (1989) J. Biol. Chem. 264, 7328.
    • 8. Lazareno, S. et al. (1990) Br. J. Pharmacol. 109, 1120.
    • 9. Hernandez, M. et al. (1993) Br. J. Pharmacol. 110, 1413.
    • 10. Manny, R.E. et al. (2001) Invest. Ophtalmol. Vis. Sci. 42, 1728.
      • Muscarinic acetylcholine receptors (mAChR) regulate a number of important basic physiologic functions including heart rate, motor and sensory control and more complex behaviors including arousal, memory, and learning. Loss of muscarinic receptor number or function has been implicated in the etiology of several neurological disorders including Alzheimer"s dementia, Down"s syndrome and Parkinson"s disease.

        Five subtypes of muscarinic receptors (m1-m5) have been identified by molecular cloning1 and much has been learned about their distribution, pharmacology, and structure2-6.

        Tropicamide is a muscarinic receptor antagonist, which shows a 3 fold selectivity for m47-8. Its effect has a pIC50 of ~7.5 for porcine intravesical ureter contraction9.

        Tropicamide produces short acting mydriasis (dilation of the pupil) and cycloplegia (paralysis of the ciliary muscle) when applied as eye drops. It is also an effective cycloplegic agent in myopic children10.

    Target M1-M5 muscarinic receptors
    receive a 250 mg free trial sample!
    Last update: 26/09/2019

    Tropicamide (#T-120) is a highly pure, synthetic, and biologically active compound.

    For research purposes only, not for human use
    Discovery®抗体是Cambridge Research Biochemicals的目录抗体业务。 CRB是全球第二大最古老的肽公司,也是抗体研究市场的先驱,目前正以Discovery®Antibodies的名义建立一系列新验证的靶标抗体。 Discovery®抗体将专注于研究用抗体(早期药物“发现”),并将补充我们非常成功且长期存在的定制抗体业务(www.crbdiscovery.com)。我们已经以新颖,复杂,稀有和翻译后修饰的特异性抗体而闻名,这些受追捧的靶标将出现在我们的Discovery®Antibody目录范围内。  我们于2017年2月,在发现肽之后一年,并且在詹姆斯·库克船长(他当时最伟大的探险家)于1776年从英国出发,乘坐“ HMS发现”号开始租用新水域和“发现全球各地的新土地。因此,“发现”这个名称似乎适合东北制造商–詹姆斯·库克的故乡。 在1700年代后期对全球新发现土地的追求与医学研究的新“发现”以及2000年人类基因组图谱的发现之间,还有其他相似之处。  有关更多详细信息,请参见有关Discovery®抗体发布的新闻稿。   Cambridge Research Biochemicals  (www.crbdiscovery.com)成立于1980年,是英国领先的定制肽和抗体工具的独立生产商,为全球制药,生命科学和学术领域的研究人员提供产品。其产品的主要应用是定制的实验室规模试剂,用于早期药物发现中的主要研究证据,并支持临床研究中的生物标志物计划。该公司生产各种口味的肽,从简单到修饰,稳定和放射性标记,再到从毫克到克到最高纯度的染料标记。此外,CRB是产生高度特异性和靶向抗体(多克隆抗体和单克隆抗体)的公认专家。荧光染料标记也是重点。自1994年以来,该公司于2016年启动了其首个目录业务DISCOVERY®。
    • 资质认证

      获得国家资质,权威认证!

    • 全国联保

      全国联保,官方无忧售后

    • 正规发票

      正规发票,放心购买

    • 签订合同

      签订合同,保障您的权益

    /**/